Tavaborole Solution
Product Images NDC 62332-467

9 FDA label images from Alembic Pharmaceuticals Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Tavaborole (NDC 62332-467). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

F2cdb18a 70bd 4b5c Af14 5365bfeb705b 01

F2cdb18a 70bd 4b5c Af14 5365bfeb705b 01
Chemical structure of Tavaborole, illustrating its molecular arrangement including a boron atom within a cyclic structure, a fluorine atom on the aromatic ring, and a hydroxyl group. This diagram represents Tavaborole's chemical composition.*
FDA Label Image

F2cdb18a 70bd 4b5c Af14 5365bfeb705b 02

F2cdb18a 70bd 4b5c Af14 5365bfeb705b 02
An instructional diagram showing hands opening a small bottle by twisting off the cap and then inserting a dropper into the bottle. The two-panel illustration demonstrates the steps to remove the cap and prepare the dropper for use with the bottle, likely associated with the Tavaborole topical solution.*
FDA Label Image

F2cdb18a 70bd 4b5c Af14 5365bfeb705b 03

F2cdb18a 70bd 4b5c Af14 5365bfeb705b 03
An instructional line drawing showing a hand holding a dropper dispensing a liquid drop onto a toenail. The illustration emphasizes topical application of the medication onto the toenail surface.*
FDA Label Image

F2cdb18a 70bd 4b5c Af14 5365bfeb705b 04

F2cdb18a 70bd 4b5c Af14 5365bfeb705b 04
An instructional illustration showing a hand holding a dropper above a toenail, applying a topical solution onto the nail surface. The image demonstrates the application method of a topical medication to the toenail area.*
FDA Label Image

F2cdb18a 70bd 4b5c Af14 5365bfeb705b 05

F2cdb18a 70bd 4b5c Af14 5365bfeb705b 05
An instructional line drawing showing the topical application of a solution to a toenail using a dropper. The image demonstrates administering drops directly on the nail and the proper technique for spreading the solution around the toenail edges with the dropper tip.*
FDA Label Image

F2cdb18a 70bd 4b5c Af14 5365bfeb705b 06

F2cdb18a 70bd 4b5c Af14 5365bfeb705b 06
Tavaborole Topical Solution 5%, 4 mL bottle label showing the product name, concentration, and route of administration. The label includes storage instructions, manufacturer Alembic Pharmaceuticals Inc. with location in Bedminster, NJ, USA, and notes the product is made in India. Barcode and NDC 62332-467-04 are visible, along with lot and expiry date placeholders.*
FDA Label Image

F2cdb18a 70bd 4b5c Af14 5365bfeb705b 07

F2cdb18a 70bd 4b5c Af14 5365bfeb705b 07
Tavaborole Topical Solution, 5% carton for a 4 mL topical solution, NDC 62332-467-04, manufactured for Alembic Pharmaceuticals Inc. The label states it is for topical use only, not for oral, ophthalmic, or intravaginal use. The label includes batch coding, storage instructions, warnings, and manufacturing details including Aleor Dermaceuticals Ltd. in India.*
FDA Label Image

F2cdb18a 70bd 4b5c Af14 5365bfeb705b 08

F2cdb18a 70bd 4b5c Af14 5365bfeb705b 08
Label for Tavaborole Topical Solution, 5% strength, in a 10 mL bottle. The label includes drug name, concentration, usage restriction (for topical use only, not for oral, ophthalmic, or intravaginal use), manufacturer Alembic Pharmaceuticals Inc., and storage instructions. It shows the NDC 62332-467-10 and states the product is made in India with a manufacture license number. Barcode and lot and expiry date areas are also depicted.*
FDA Label Image

F2cdb18a 70bd 4b5c Af14 5365bfeb705b 09

F2cdb18a 70bd 4b5c Af14 5365bfeb705b 09
Carton label for Tavaborole Topical Solution, 5%, 10 mL, manufactured by Alembic Pharmaceuticals Inc. The label includes drug strength (43.5 mg/mL tavaborole), topical solution dosage form, and instructions restricting use to topical application only. The carton displays storage instructions, caution about flammability, and a barcode. NDC 62332-467-10 is visible on multiple panels.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.